What's new? Log in Free sign up

Filing search / Kineta, Inc. / "Employee Retention"

Search information

Kineta, Inc.

Companies

"Employee Retention"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

23 results

Newest first Best match first

KANT Kineta, Inc.

Quarterly report

Exercised Forfeited Expired Outstanding as of June 30, 2024 Exercisable as of June 30, 2024 Annual Stock Awards and Employee Retention Policy On April … 30, 2023 and $69,000 for the six months ended June 30, 2023. 12.Related Party Transactions Annual Stock Awards and Employee Retention Policy

8 Aug 24

4:00pm

KANT Kineta, Inc.

Quarterly report

subsequent events through the date these consolidated financial statements were issued. Annual Stock Awards and Employee Retention Policy On April 11 … , 2024, the Compensation Committee of the Board approved and on April 14, 2024, the Board approved and adopted the Annual Stock Awards and Employee

15 May 24

4:05pm

KANT Kineta, Inc.

Departure of Directors or Certain Officers

Officers; Compensatory Arrangements of Certain Officers. Annual Stock Awards and Employee Retention Policy On April 11, 2024, the Compensation … Stock Awards and Employee Retention Policy (the “Policy”), which will provide retention awards to key employees, including certain of the Company’s

KANT Kineta, Inc.

Kineta Completes Reverse Merger with Yumanity Therapeutics

and competitors to the announcement or completion of the merger, and/or potential difficulties in employee retention as a result of the announcement or completion

KANT Kineta, Inc.

Quarterly report

-level, and senior scientific and medical personnel. While we committed to pay one-time employee retention payments to certain employees at the time we

14 Nov 22

8:44am

1x92db3suy23lm1hyx

Prospectus supplement

cviu9wt9p4vjggm

Registration of securities issued in business combination transactions (amended)

4 Nov 22

4:49pm

i6xtf2vsdpxf73zjjfo

Registration of securities issued in business combination transactions (amended)

24 Oct 22

9:14am

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

Registration of securities issued in business combination transactions

29 Aug 22

12:00am

Quarterly report

4 Aug 22

5:12pm

Quarterly report

12 May 22

4:59pm

24 Mar 22

4:31pm

Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring

Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics

u3p43fflw770obev4l4z

Business combination disclosure

Prospectus supplement

Registration of securities issued in business combination transactions (amended)

6 Nov 20

4:43pm

Registration of securities issued in business combination transactions (amended)

28 Oct 20

4:59pm

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.